<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04096482</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00110282</org_study_id>
    <nct_id>NCT04096482</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of the Peregrine Drivable ENT Scope for Endoscopy of the Paranasal Sinuses</brief_title>
  <official_title>Safety and Effectiveness Evaluation of the Peregrine Drivable ENT Scope for Office Endoscopy of the Paranasal Sinuses in Patients Who Underwent ESS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>3NT Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and effectiveness of the Peregrine&#xD;
      endoscope in patients in the office setting in terms of access into and visualization of the&#xD;
      paranasal sinus anatomy, image quality, patient tolerability and clinical utility. Up to 30&#xD;
      participants who have had prior endoscopic sinus surgery (ESS) and are scheduled for nasal&#xD;
      endoscopy in the office as part of a routine post-operative office visit or due to recurrence&#xD;
      of symptoms, will be evaluated with the Peregrine Endoscope as well as a standard endoscope.&#xD;
      This study aims to:&#xD;
&#xD;
        -  compare visualization success rates of the paranasal sinus anatomy by Peregrine and by a&#xD;
           standard endoscope used in the office setting.&#xD;
&#xD;
        -  examine device related adverse events.&#xD;
&#xD;
        -  assess the adequacy of the image quality of Peregrine for endoscopy procedures in the&#xD;
           office.&#xD;
&#xD;
        -  evaluate patient tolerability and pain&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nasal endoscopy is a minimally invasive, diagnostic medical procedure and currently the most&#xD;
      preferred initial method of evaluating medical problems affecting nose and sinuses such as&#xD;
      nasal stuffiness and obstruction, sinusitis, nasal polyposis, nasal tumors, epistaxis,&#xD;
      recurrent bouts of sneezing and rhinorrhea. Overall, the procedure is considered very safe&#xD;
      and low-risk. Currently, nasal endoscopy can be performed with a flexible or rigid endoscope,&#xD;
      typically after a topical decongestant and anesthetic are applied to the nasal mucosa.&#xD;
&#xD;
      Reprocessing is an issue of concern, especially for flexible endoscopes where multiple steps&#xD;
      were confirmed to be critical for reprocessing to be effective. High-level disinfection has&#xD;
      been determined to be the minimum level of disinfection required, which involves multiple&#xD;
      steps including manual cleaning, leak testing, cleaning with an enzymatic agent, high-level&#xD;
      disinfection, and drying with vertical storage. 3NT Medical Ltd. has developed the Peregrine&#xD;
      Drivable Ear Nose and Throat (ENT) Scope, which offers the convenience of a single-use&#xD;
      endoscope component coupled with performance characteristics of commercially available&#xD;
      state-of-the-art reusable endoscopy systems. The single-use endoscope essentially removes&#xD;
      concerns related to burdensome reprocessing techniques of a delicate tool required to achieve&#xD;
      high-level of its disinfection.&#xD;
&#xD;
      The objective of this study is to assess the safety and performance of the Peregrine&#xD;
      endoscope in patients in the office setting in terms of access and visualization of the&#xD;
      paranasal sinus anatomy, image quality, and patient tolerability and pain. For this study, up&#xD;
      to 30 patients who have had prior endoscopic sinus surgery (ESS) and who are scheduled for&#xD;
      nasal endoscopy in the office, as part of a routine post-operative office visit or due to&#xD;
      recurrence of symptoms, will be evaluated with Peregrine Endoscope. Access and visualization&#xD;
      by an additional standard endoscope will be conducted and compared to Peregrine endoscope.&#xD;
      Image quality of the Peregrine endoscope, participant tolerability and pain, and the impact&#xD;
      of Peregrine on clinical decision making will be evaluated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Early findings identified the need to update the design of the study device.&#xD;
  </why_stopped>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Actual">September 1, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients who have had prior ESS and are scheduled for nasal endoscopy as part of a routine post-operative office visit or due to recurrence of symptoms will be evaluated with the standard endoscope followed by the Peregrine Endoscope.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Visualization Success of Maxillary Sinus Anatomy</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>The ability of each endoscope type to visualize the maxillary sinus anatomy (ostium, floor, lateral recess, anterior wall) was assessed as being a success or failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Visualization Success of Frontal Sinus Anatomy</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>The ability of each endoscope type to visualize the frontal sinus anatomy (ostium, posterior table, anterior table, lateral recess) was assessed as being a success or failure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Visualization Success of Sphenoid Sinus Anatomy</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>The ability of each endoscope type to visualize the sphenoid sinus anatomy (ostium, sella, floor, lateral aspect) was assessed as being a success or failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Adequate or Inadequate Image Quality From Peregrine Endoscopy</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>Image quality will be assessed through a yes/no statement, reported by physicians, regarding the adequacy of the Peregrine image quality for making clinical decisions in the office setting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) Tolerability Score</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>Participant tolerability was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = highly tolerable and 10 = not tolerable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Pain Score</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>Participant pain was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = no pain and 10 = pain as bad as it could be.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on Clinical Workflow</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>The impact on clinical workflow of visual information obtained by each endoscope procedures was rated by physicians on a 5-point scale where 1 = worst and 5 = best.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of Use</measure>
    <time_frame>Day 1 (after each endoscopy)</time_frame>
    <description>The ease of use of each endoscope procedure was rated by physicians on a 5-point scale where 1 = worst and 5 = best.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Sinus Problem</condition>
  <arm_group>
    <arm_group_label>Standard 30° 4mm Endoscope Followed by Peregrine Endoscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive an endoscopy with the standard 30° 4mm endoscope followed by an endoscopy with the Peregrine Drivable ENT Scope.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Peregrine Drivable ENT Scope</intervention_name>
    <description>Peregrine, developed by 3NT Medical, is a single-use disposable handheld endoscope, which is thinner and more flexible than other endoscopes. The endoscope includes a camera at its end and a working channel. The thin endoscope provides a means to visualize the nasal cavity and paranasal sinus space and to deliver irrigation to treat the sinus ostia (drainage openings) and spaces within the paranasal sinus cavities</description>
    <arm_group_label>Standard 30° 4mm Endoscope Followed by Peregrine Endoscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard 30° 4mm Endoscope</intervention_name>
    <description>The Standard 30° 4mm endoscopic sinus evaluation is the standard procedure that would normally be used to evaluate the condition of each participant.</description>
    <arm_group_label>Standard 30° 4mm Endoscope Followed by Peregrine Endoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A male or female patient who has had prior ESS and who is indicated for office&#xD;
             endoscopy by the ENT specialist&#xD;
&#xD;
          -  A patient who is able to understand the requirements of the study, is willing to&#xD;
             comply with its instructions and schedules, and agrees to sign the informed consent&#xD;
             form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any medical disorder which in the investigator's judgment contraindicates the&#xD;
             patient's participation&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua Levy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory Hospital Midtown</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <results_first_submitted>August 24, 2021</results_first_submitted>
  <results_first_submitted_qc>August 24, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 20, 2021</results_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Joshua M. Levy</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Nasal endoscopy</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All individual participant data collected during the trial and after deidentification will be available for sharing.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available for sharing immediately following the embargo period associated with publication.</ipd_time_frame>
    <ipd_access_criteria>Data will be available for sharing with primary investigators at academic institutions for the purposes of meta-analysis or nested studies with agreed publication plan. Data can be requested by contacting the study team and completing a data sharing agreement.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/82/NCT04096482/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from Emory University Hospital Midtown in Atlanta, Georgia, USA. Participant enrollment began November, 5, 2019 and all follow up was complete by September 1, 2020.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Standard 30° 4mm Endoscope Followed by Peregrine Endoscope</title>
          <description>Participants with prior endoscopic sinus surgery (EES) scheduled for nasal endoscopy who are receiving an endoscopy with the standard 30° 4mm endoscope followed by an endoscopy with the Peregrine Drivable Ear Nose and Throat (ENT) Scope.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Endoscope Followed by Peregrine Drivable ENT Scope</title>
          <description>Participants with prior endoscopic sinus surgery (EES) scheduled for nasal endoscopy who are receiving an endoscopy with the standard 30° 4mm endoscope followed by an endoscopy with the Peregrine Drivable ENT Scope.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.83" spread="17.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Visualization Success of Maxillary Sinus Anatomy</title>
        <description>The ability of each endoscope type to visualize the maxillary sinus anatomy (ostium, floor, lateral recess, anterior wall) was assessed as being a success or failure.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Visualization Success of Maxillary Sinus Anatomy</title>
          <description>The ability of each endoscope type to visualize the maxillary sinus anatomy (ostium, floor, lateral recess, anterior wall) was assessed as being a success or failure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Left Ostium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Ostium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Floor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Floor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Lateral Recess</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Lateral Recess</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Anterior Wall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Anterior Wall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Visualization Success of Frontal Sinus Anatomy</title>
        <description>The ability of each endoscope type to visualize the frontal sinus anatomy (ostium, posterior table, anterior table, lateral recess) was assessed as being a success or failure.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Visualization Success of Frontal Sinus Anatomy</title>
          <description>The ability of each endoscope type to visualize the frontal sinus anatomy (ostium, posterior table, anterior table, lateral recess) was assessed as being a success or failure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Left Ostium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Ostium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Posterior Table</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Posterior Table</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Anterior Table</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Anterior Table</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Lateral Recess</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Lateral Recess</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Visualization Success of Sphenoid Sinus Anatomy</title>
        <description>The ability of each endoscope type to visualize the sphenoid sinus anatomy (ostium, sella, floor, lateral aspect) was assessed as being a success or failure.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Visualization Success of Sphenoid Sinus Anatomy</title>
          <description>The ability of each endoscope type to visualize the sphenoid sinus anatomy (ostium, sella, floor, lateral aspect) was assessed as being a success or failure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Left Ostium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Ostium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Sella</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Sella</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Floor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Floor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Lateral Aspect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Right Lateral Aspect</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Adequate or Inadequate Image Quality From Peregrine Endoscopy</title>
        <description>Image quality will be assessed through a yes/no statement, reported by physicians, regarding the adequacy of the Peregrine image quality for making clinical decisions in the office setting.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adequate or Inadequate Image Quality From Peregrine Endoscopy</title>
          <description>Image quality will be assessed through a yes/no statement, reported by physicians, regarding the adequacy of the Peregrine image quality for making clinical decisions in the office setting.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Adequate image quality</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Inadequate image quality</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analogue Scale (VAS) Tolerability Score</title>
        <description>Participant tolerability was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = highly tolerable and 10 = not tolerable.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analogue Scale (VAS) Tolerability Score</title>
          <description>Participant tolerability was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = highly tolerable and 10 = not tolerable.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.98" spread="1.72"/>
                    <measurement group_id="O2" value="2.52" spread="3.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VAS Pain Score</title>
        <description>Participant pain was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = no pain and 10 = pain as bad as it could be.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>VAS Pain Score</title>
          <description>Participant pain was evaluated through validated VAS for both endoscopies. Scores range from 1 to 10, where 1 = no pain and 10 = pain as bad as it could be.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.75" spread="1.79"/>
                    <measurement group_id="O2" value="4.13" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Impact on Clinical Workflow</title>
        <description>The impact on clinical workflow of visual information obtained by each endoscope procedures was rated by physicians on a 5-point scale where 1 = worst and 5 = best.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Impact on Clinical Workflow</title>
          <description>The impact on clinical workflow of visual information obtained by each endoscope procedures was rated by physicians on a 5-point scale where 1 = worst and 5 = best.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="1.55"/>
                    <measurement group_id="O2" value="5" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ease of Use</title>
        <description>The ease of use of each endoscope procedure was rated by physicians on a 5-point scale where 1 = worst and 5 = best.</description>
        <time_frame>Day 1 (after each endoscopy)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Peregrine Drivable ENT Scope</title>
            <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
          </group>
          <group group_id="O2">
            <title>Standard 30° 4mm Endoscope</title>
            <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
          </group>
        </group_list>
        <measure>
          <title>Ease of Use</title>
          <description>The ease of use of each endoscope procedure was rated by physicians on a 5-point scale where 1 = worst and 5 = best.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="6"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.67" spread="1.37"/>
                    <measurement group_id="O2" value="5" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Information on adverse events was collected beginning at the start of the procedure through the follow-up telephone call which occurred up to 2 weeks and 3 days after the procedure.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Peregrine Drivable ENT Scope</title>
          <description>Participants receiving an endoscopy with the Peregrine Drivable ENT scope.</description>
        </group>
        <group group_id="E2">
          <title>Standard 30° 4mm Endoscope</title>
          <description>Participants receiving an endoscopy with the standard 30° 4mm endoscope.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="6"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="6"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joshua M Levy</name_or_title>
      <organization>Emory University</organization>
      <phone>(404) 778-3381</phone>
      <email>joshua.levy2@emory.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

